TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. by Avery, A. et al.
Br. J. Cancer (1993), 68, 137-139 1993
TGF-P expression in the human colon: differential immunostaining along
crypt epithelium
A. Avery', C. Paraskeval, P. Hall', K.C. Flanders2, M. Sporn2 & M. Moorghen1
'Department ofPathology and Microbiology, School ofMedical Sciences University ofBristol, Bristol BS8 ITH, UK; 2Laboratory
ofChemoprevention, National Cancer Institute, Bethesda, Maryland 20892, USA.
Summary Samples of colorectal carcinoma, adenoma and normal colorectal mucosa were examined for the
expression of TGF-P by immunohistochemistry. Immunoreactivity for TGF-P was present in 52 out of a total
of 58 samples of normal mucosa examined. In adenomas and carcinomas TGF-P expression was observed in
eight out of ten and 46 out of 48 samples respectively and was largely restricted to epithelial cells. In normal
mucosa differential expression of TGF-,B was present within epithelial cells, those in the upper parts of the
crypts showing enhanced immunoreactivity compared to cells in the proliferative compartment. This pattern of
differential staining is consistent with TGF-1 having an important role in the control of growth and
differentiation in colonic mucosa.
TGF-P belongs to a family of polypeptides with diverse
biological functions which include the stimulation or inhibi-
tion of cell proliferation, enhancement of cell differentiation
and stimulation of extracellular matrix formation. TGF-P
thus plays a central role in the control of cell growth in
normal adult tissues, in embryonic development and also in
carcinogenesis (Roberts et al., 1988). Molecular events which
regulate TGF-13 activity are not well understood although the
inhibition of epithelial cell proliferation by TGF-P which is
an almost universal phenomenon is possibly related to c-myc
down-regulation (Barnard et al., 1990). A number of studies
have shown TGF-13 mRNA to be expressed in a variety of
human and rodent adult tissues. These studies suggest that
TGF-P expression is often associated with the differentiated
phenotype; thus in the mouse small bowel mucosa TGF-P
expression is maximal at the villus tip (Barnard et al., 1990).
These studies led Barnard et al. (1990) to conclude that
TGF-,B may function in the co-ordination of the rapid cell
turnover typical of intestinal epithelium. Of further interest
has been the report that human colonic adenoma cell lines
are more sensitive to the growth inhibitory effects of TGF-P
than are colorectal cancer cell lines (Manning et al., 1991).
Furthermore the conversion of an adenoma cell line to a
carcinoma cell line is accompanied by a reduced response to
the inhibitory effects of TGF-P. It was therefore concluded
that reduced responsiveness to the inhibitory effects of TGF-P
may be an important event in the loss of growth control in
colorectal carcinogenesis (Manning et al., 1991). Whereas
there is therefore good evidence to support a role for TGF-P
in growth control of normal and neoplastic colonic mucosa,
the expression of TGF-P in human colonic tissues is by and
large poorly documented. Using a panel of antibodies which
recognise different epitopes of mature TGF-P1 and pro-
TGF-p1, Flanders and colleagues (1989) have demonstrated
variable staining patterns in a number of tumours including
carcinoma of the colon. In this study we have examined both
normal and neoplastic colonic tissues for the expression of
TGF-P as determined by immunohistochemistry using a
polyclonal antibody raised against TGF-131. We were partic-
ularly interested in determining whether in the normal human
large bowel as in the mouse small bowel there was a
differential expression of TGF-,1I along the crypt which cor-
related with the state of differentiation of the epithelial cells.
Materials and methods
Tissues
Formalin-fixed paraffin-embedded material obtained from the
files of the Department ofPathology, Bristol Royal Infirmary
were used. Forty-eight samples of colonic carcinoma and ten
samples of colonic adenoma were examined. Adjacent 'nor-
mal' mucosa was included in 48 out of the total of 58
specimens examined. In addition ten samples of normal col-
onic mucosa taken from specimens not harbouring a tumour
were also examined.
Immunohistochemistry
A standard streptavidin-biotin technique was employed using
a well characterised polyclonal antibody raised against TGF-
P1 (Wakefield et al., 1987). This antibody was raised in
rabbits using synthetic peptides corresponding to amino acids
266-278 of human pro-TGF-P3 and has been shown to
recognise intracellular TGF-P in tumour cells which are
known to express and produce this protein (Flanders et al.,
1989). In our experiments trypsinisation was found to be
unnecessary. In each experiment negative controls were
examined where the primary antibody was omitted with or
without normal rabbit serum. Slides were scored as strongly
positive (+), weakly positive (±) or negative (-).
Results
Mucosa
Positive staining of epithelial cells was present in nine out of
ten samples of normal colonic mucosa taken from specimens
which did not harbour a tumour. Staining intensity was more
marked within surface epithelial cells and became progres-
sively weaker in cells situated more deeply within the crypts
(Figure 1). In 48 out of a total of 58 tumour samples
examined mucosa was also included in the tissue sections.
Positive staining of mucosal epithelial cells was present in 43
out of these 48 samples (Table I). In these positive cases
within areas which showed no evidence of dysplasia and no
features of so-called transitional mucosa (Filipe, 1984) the
staining pattern was identical to that seen in the ten samples
of normal mucosa taken from specimens not harbouring a
tumour. In areas situated immediately adjacent to tumour
the gradient of staining was lost, with all epithelial cells
showing uniform intensity of staining irrespective of whether
these areas showed dysplastic changes, transitional mucosa
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Table II Expression ofTGF-P in colonic carcinoma
Staining intensity
Tumour grade + +
Well differentiated 11 4 1
Moderately differentiated 12 3 1
Poorly differentiated 13 3 0
Total 36 10 2
% of total 75 21 4
Figure I Immunohistochemical staining for TGF-P in colorectal
mucosa.
Table IA Expression ofTGF-P in colonic mucosa
Staining intensity
+ +_
Number of samples 9 0 1
% of total 90 0 10
Table IB Expression of TGF-P in colonic mucosa (taken from
specimens harbouring a tumour)
Staining intensity
+ +_
Number of samples 32 11 5
% of total 67 23 10
changes or appeared normal. Immunoreactivity was also
noted in smooth muscle cells and within some lymphoid cells
in the lamina propria.
Carcinoma
Positive staining of tumour cells were present in 46 out of 48
samples examined (Table II, Figure 2). Immunoreactivity was
largely restricted to epithelial cells and showed a diffuse
cytoplasmic pattern; positive staining was also observed in
occasional adipocytes, stromal fibroblasts and also within
macrophages and a few lymphoid cells. Positive staining
where present was seen in almost all neoplastic cells (>90%)
except in three cases where a patchy distribution was
Figure 2 Immunohistochemical staining for TGF-P in colorectal
carcinoma.
observed with only up to 10% of the cells showing positive
staining in some areas. Two of these three tumours were
poorly differentiated adenocarcinomas and one was a
mucinous carcinoma. Immunostaining overall did not how-
ever appear to relate to grade of differentiation (Table II).
Adenoma
Nine out of the ten adenomas were positive for TGF-P
(Table III). The pattern of staining was similar to that seen
in invasive carcinoma in that there was diffuse cytoplasmic
staining of all epithelial cells. Within the stroma positive
immunoreactivity was observed in macrophages and a few
lymphoid cells.
Discussion
The expression of TGF-3 mRNA in cell lines and primary
human tumours arising in different tissues is well documentedDIFFERENTIAL TGF-P EXPRESSION IN HUMAN COLON 139
Table III Expression of TGF-,B in colonic adenoma
Staining intensity
+ +
Number of samples 8 1 1
% of total 80 10 10
and it appears that by and large tumour levels are enhanced
compared to normal tissues (Derynck et al., 1987). In this
study we report the presence ofTGF-P in normal large bowel
mucosa, colorectal carcinomas and colorectal adenomas.
Immunoreactivity for TGF-P was predominantly present in
epithelial cells in the tumours examined which suggest that
the site of TGF-P production is largely restricted to the
epithelial component. One of the three tumours in which
TGF-P showed a patchy distribution was in mucinous car-
cinoma which was characterised by the presence of large
amounts of intercellular mucin and very little stroma. The
relative lack of TGF-,B expression in this tumour is in keep-
ing with the ability of TGF-f to stimulate the formation of
extracellular matrix. Although TGF-P expression is generally
a reflection of cellular differentiation, tumour grade in this
study was not associated with any change in TGF-f expres-
sion. In normal mucosa TGF-P immunoreactivity showed a
striking distribution being present in the upper parts of the
crypts which are populated by more differentiated cells, and
absent deeply within the crypts in the proliferating cell com-
partment. This finding is similar to that observed in the
rodent large bowel in a different study in which the same
antibody was employed (Glick et al., 1991) and conforms to
the concept of TGF-P being a feature of the differentiated
phenotype. This gradient of staining along the crypt was lost
in both dysplastic mucosa and morphologically normal
mucosa situated immediately adjacent to tumour. This loss of
staining gradient in mucosa showing no significant his-
tological abnormality compared to tumour is of potential
interest. It raises the possibility that de-regulation of TGF-P
expression occurs as an early event in colorectal car-
cinogenesis prior to adenoma formation; alternatively it
could represent a field effect. To the best of our knowledge
this is the first study reporting the presence and differential
distribution of TGF-P in human colorectal mucosa.
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